Efficacy and Renal Safety of Long-Term Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Normal or Mild Renal Dysfunction (eGFR ≥60 mL/min/1.73m2)

被引：0

作者：

Kim, In Hee ^{[1
]}

Lee, Chang Hun ^{[1
]}

Kim, Seong Hun ^{[1
]}

Kim, Sang Nook ^{[1
]}

Lee, Seung Ok ^{[1
]}

Lee, Soo Teik ^{[1
]}

机构：

[1] Chonbuk Natl Univ, Sch Med, Res Inst Clin Med, Biomed Res Inst,Chonbuk Natl Univ Hosp, Jeonju, South Korea

来源：

HEPATOLOGY | 2018年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

410

引用

页码：244A / 244A

页数：1

共 50 条

[1] Renal Safety of Long-term Tenofovir Disoproxil Fumarate Treatment in Patients With Chronic Hepatitis B
Woldemedihn, Gezahegn M.
Aberra, Hanna
Desalegn, Hailemichael
Berhe, Nega
Belay, Denekew Bitew
Rueegg, Corina S.
Johannessen, Asgeir
OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (08):
[2] Long-term renal and bone safety of tenofovir disoproxil fumarate in chronic hepatitis B patients
Butt, N.
Rai, L.
Hussain, R.
Khemani, H.
Ali, S.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 84 - 84
[3] Long-term renal and bone safety of tenofovir disoproxil fumarate in chronic hepatitis B patients with cirrhosis
Liu, Ken
Choi, Jonggi
Le, An
Wong, Vincent Wai-Sun
Chan, Stephen L.
Nguyen, Mindie
Lim, Young-Suk
Wong, Grace Lai-Hung
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E475 - E476
[4] An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate
Lim, Tae Seop
Lee, Jae Seung
Kim, Beom Kyung
Lee, Hye Won
Jeon, Mi Young
Kim, Seung Up
Park, Jun Yong
Kim, Do Young
Han, Kwang-Hyub
Ahn, Sang Hoon
JOURNAL OF VIRAL HEPATITIS, 2020, 27 (03) : 316 - 322
[5] Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
Xieer Liang
Zhiliang Gao
Qing Xie
Jiming Zhang
Jifang Sheng
Jun Cheng
Chengwei Chen
Qing Mao
Wei Zhao
Hong Ren
Deming Tan
Junqi Niu
Shijun Chen
Chen Pan
Hong Tang
Hao Wang
Yimin Mao
Jidong Jia
Qin Ning
Min Xu
Shanming Wu
Jun Li
Xinxin Zhang
Wenyan Zhang
Cui Xiong
Jinlin Hou
Hepatology International, 2019, 13 : 260 - 269
[6] Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
Liang, Xieer
Gao, Zhiliang
Xie, Qing
Zhang, Jiming
Sheng, Jifang
Cheng, Jun
Chen, Chengwei
Mao, Qing
Zhao, Wei
Ren, Hong
Tan, Deming
Niu, Junqi
Chen, Shijun
Pan, Chen
Tang, Hong
Wang, Hao
Mao, Yimin
Jia, Jidong
Ning, Qin
Xu, Min
Wu, Shanming
Li, Jun
Zhang, Xinxin
Zhang, Wenyan
Xiong, Cui
Hou, Jinlin
HEPATOLOGY INTERNATIONAL, 2019, 13 (03) : 260 - 269
[7] An Observational Study about Long-Term Renal Outcome in Chronic Hepatitis B Patients Treated with Tenofovir Disoproxil Fumarate in Korea
Lim, Tae Seop
Lee, Hye Won
Jeon, Mi Young
Kim, Beom Kyung
Kim, Seung Up
Park, Jun Yong
Kim, Do Young
Han, Kwang-Hyub
Ahn, Sang Hoon
HEPATOLOGY, 2018, 68 : 1232A - 1232A
[8] Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B Patients
Mingxing Huang
Yusheng Jie
Guoli Lin
Hong Shi
Xinhua Li
Xiangyong Li
Yuankai Wu
Yutian Chong
Clinical Drug Investigation, 2016, 36 : 471 - 478
[9] Efficacy of long-term tenofovir disoproxil fumarate therapy in chronic hepatitis B patients with partial virologic response in real practice
Song, Jeong Eun
Lee, Chang Hyeong
Kim, Byung Seok
KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (04): : 802 - +
[10] Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B Patients
Huang, Mingxing
Jie, Yusheng
Lin, Guoli
Shi, Hong
Li, Xinhua
Li, Xiangyong
Wu, Yuankai
Chong, Yutian
CLINICAL DRUG INVESTIGATION, 2016, 36 (06) : 471 - 478

← 1 2 3 4 5 →